de Quervain's tenosynovitis. Radial styloid tenosynovitis [de Quervain]
Conditions
Interventions
Intervention 1: Intervention Group: All patients in this group will be provided with one dose injection of "Methyl-prednisolon acetate" 40 milligrams plus 1 milliliter of "lidocaine"2 %( 60 milligrams
Treatment - Other
Treatment - Drugs
Intervention Group: All patients in this group will be provided with one dose injection of "Methyl-prednisolon acetate" 40 milligrams plus 1 milliliter of "lidocaine"2 %( 60 milligrams) in the maximal
Control group: All patients in this group will be provided with one dose injection of "Methyl-prednisolon acetate" 40 milligrams plus 1 milliliter of "lidocaine"2% (60 milligrams) in the maximal point
Sponsors
Vice Chancellor for Research, Guilan University of Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Inclusion criteria: All patients should have 4 criteria: Pain at the radial wrist; Tenderness at the first dorsal extensor compartment; A positive Finkelstein test; and VAS score more than 6. Exclusion criteria: Pregnancy; and history of rheumatoid arthritis.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Successful treatment that explained as lack of the three criteria: 1) Pain at the radial wrist. 2) Tenderness at the first dorsal extensor compartment. 3) A positive Finkelstein test. Timepoint: refer time and 3 weeks after treatment. Method of measurement: History and physical examination. | — |
Secondary
| Measure | Time frame |
|---|---|
| Pain severity. Timepoint: before treatment and 3 weeks after treatment. Method of measurement: value-added service (VAS) score.;Disability of elbow score. Timepoint: before treatment and 3 weeks after treatment. Method of measurement: The Disabilities of the Arm, Shoulder and Hand Score(QuickDash). | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Mohsen Mardani Kivi
Guilan University of Medical Science
Outcome results
None listed